The frequency and depth of conversations happening online among people who share a disease far outpace those that happen between a patient and his or her physician. In these patient communities, people share the unfiltered truth - about their disease, their drugs and their daily lives. This unprecedented level of authentic conversation offers real-world insight into the patient experience. By aggregating and analyzing this data, innovative biopharma companies are gaining actionable insights into unmet patient needs. This fundamental transformation to a patient-centric model is revealing misconceptions, improving health outcomes and unlocking valuable opportunities across the ecosystem.
Never before have the lines of communication been so open between biotech and pharma companies and their consumers. With this in mind, panelists will explore why companies still struggle to understand the patient perspective and why patients continue to feel misunderstood.

Ability Level: All

Session ID: 21119